Shaanxi Meibang Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 6/6
Shaanxi Meibang Pharmaceutical Group has a total shareholder equity of CN¥1.1B and total debt of CN¥73.0M, which brings its debt-to-equity ratio to 6.4%. Its total assets and total liabilities are CN¥1.8B and CN¥620.2M respectively. Shaanxi Meibang Pharmaceutical Group's EBIT is CN¥11.0M making its interest coverage ratio -1.4. It has cash and short-term investments of CN¥523.2M.
Key information
6.4%
Debt to equity ratio
CN¥73.00m
Debt
| Interest coverage ratio | -1.4x |
| Cash | CN¥523.18m |
| Equity | CN¥1.14b |
| Total liabilities | CN¥620.20m |
| Total assets | CN¥1.76b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 605033's short term assets (CN¥1.1B) exceed its short term liabilities (CN¥369.2M).
Long Term Liabilities: 605033's short term assets (CN¥1.1B) exceed its long term liabilities (CN¥251.0M).
Debt to Equity History and Analysis
Debt Level: 605033 has more cash than its total debt.
Reducing Debt: 605033's debt to equity ratio has reduced from 10.6% to 6.4% over the past 5 years.
Debt Coverage: 605033's debt is well covered by operating cash flow (474.2%).
Interest Coverage: 605033 earns more interest than it pays, so coverage of interest payments is not a concern.